Niche leadership Unique position as the only center worldwide implementing Dr. Shipon-Blum's S-CAT program, presenting a strong differentiator for partnerships with schools, clinics, and insurers seeking validated SM treatment expertise.

Targeted market Focus on children and teens with Selective Mutism and related social communication disorders suggests collaboration opportunities with pediatric practices, school districts, and family therapy networks seeking specialized interventions.

Proven impact S-CAT treatment backed by extensive global use (over 5,000 children) can be leveraged in case studies and pilot programs with partners aiming to improve outcomes and program adoption.

Growth potential Revenue range indicates a midsize operation with room to scale through training licensing, clinician certification, or research collaborations with larger behavioral health organizations.

Digital & outreach synergy Existing tech stack and online presence offer entry points for marketing partnerships, telehealth expansion, and data-driven outreach to educators, clinicians, and parents.